Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans - PubMed (original) (raw)
Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans
J Grøndahl-Hansen et al. Am J Pathol. 1991 Jan.
Abstract
Human colon adenocarcinomas and adjacent normal colon tissues were stained immunohistochemically with three different monoclonal antibodies and one preparation of polyclonal antibodies against each of the two plasminogen activators, uPA (urokinase type) and tPA (tissue type). The staining patterns seen with the respective sets of antibodies were identical. In all of 10 cases, staining for uPA in the normal colon tissue was confined to scattered fibroblastlike cells in the lamina propria. Other cells, including epithelial and endothelial cells, were uPA negative. All the tumor infiltrates contained many more uPA-positive cells than the normal tissues, but the staining was confined to fibroblastlike cells and endothelial cells in the tumor stroma, while no staining of the malignant epithelial cells was detected. Analysis for uPA by enzyme-linked immunosorbent assay (ELISA) in four cases showed an average uPA content of 0.15 ng uPA/mg protein in the normal colon tissues and 1.6 ng uPA/mg protein in the tumors. Tissue-type plasminogen activator immunoreactivity was confined to endothelial cells in both the normal colon tissue and in the colon carcinomas. These findings may indicate that colon cancer cells recruit stromal cells to produce uPA involved in degradation of the extracellular matrix during invasive growth.
Similar articles
- Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas.
Pyke C, Kristensen P, Ralfkiaer E, Grøndahl-Hansen J, Eriksen J, Blasi F, Danø K. Pyke C, et al. Am J Pathol. 1991 May;138(5):1059-67. Am J Pathol. 1991. PMID: 1850957 Free PMC article. - Impact of urokinase-type plasminogen activator and its inhibitor type 1 on prognosis in cervical cancer of the uterus.
Kobayashi H, Fujishiro S, Terao T. Kobayashi H, et al. Cancer Res. 1994 Dec 15;54(24):6539-48. Cancer Res. 1994. PMID: 7987854 - Plasminogen Activators in Neurovascular and Neurodegenerative Disorders.
Yepes M, Woo Y, Martin-Jimenez C. Yepes M, et al. Int J Mol Sci. 2021 Apr 22;22(9):4380. doi: 10.3390/ijms22094380. Int J Mol Sci. 2021. PMID: 33922229 Free PMC article. Review. - Plasminogen activators in (pre)malignant conditions of the colorectum.
Verspaget HW, Verheijen JH, de Bruin PA, Griffioen G, Lamers CB. Verspaget HW, et al. Eur J Cancer Clin Oncol. 1989 Mar;25(3):565-9. doi: 10.1016/0277-5379(89)90272-1. Eur J Cancer Clin Oncol. 1989. PMID: 2649380 Review.
Cited by
- Complementation between urokinase-producing and receptor-producing cells in extracellular matrix degradation.
Quax PH, Pedersen N, Masucci MT, Weening-Verhoeff EJ, Danø K, Verheijen JH, Blasi F. Quax PH, et al. Cell Regul. 1991 Oct;2(10):793-803. doi: 10.1091/mbc.2.10.793. Cell Regul. 1991. PMID: 1666303 Free PMC article. - A regulatory element that mediates co-operation between a PEA3-AP-1 element and an AP-1 site is required for phorbol ester induction of urokinase enhancer activity in HepG2 hepatoma cells.
Nerlov C, De Cesare D, Pergola F, Caracciolo A, Blasi F, Johnsen M, Verde P. Nerlov C, et al. EMBO J. 1992 Dec;11(12):4573-82. doi: 10.1002/j.1460-2075.1992.tb05559.x. EMBO J. 1992. PMID: 1330539 Free PMC article. - Demonstration of urokinase expression in cancer cells of colon adenocarcinomas by immunohistochemistry and in situ hybridization.
Harvey SR, Sait SN, Xu Y, Bailey JL, Penetrante RM, Markus G. Harvey SR, et al. Am J Pathol. 1999 Oct;155(4):1115-20. doi: 10.1016/S0002-9440(10)65214-5. Am J Pathol. 1999. PMID: 10514394 Free PMC article. - Secretion of urokinase and plasminogen activator inhibitor-1 by normal colonic epithelium in vitro.
Gibson P, Rosella O, Rosella G, Young G. Gibson P, et al. Gut. 1994 Jul;35(7):969-75. doi: 10.1136/gut.35.7.969. Gut. 1994. PMID: 8063226 Free PMC article. - Urokinase-receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor beta 1 in human A549 lung carcinoma cells.
Lund LR, Rømer J, Rønne E, Ellis V, Blasi F, Danø K. Lund LR, et al. EMBO J. 1991 Nov;10(11):3399-407. doi: 10.1002/j.1460-2075.1991.tb04904.x. EMBO J. 1991. PMID: 1655420 Free PMC article.
References
- J Cell Biol. 1989 May;108(5):1987-95 - PubMed
- Cancer Res. 1988 May 15;48(10):2825-31 - PubMed
- J Biol Chem. 1989 Feb 5;264(4):2185-8 - PubMed
- Gut. 1987 Jul;28(7):816-21 - PubMed
- J Cell Biol. 1987 Apr;104(4):801-4 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous